A +229% biotech

By kmoffitt, June 10, 2014

So many biotechs, so little time. A biotech, IDIX, gained 229% today on news that Merck will be buying this company that is developing a hepatitis C drug. It always amazes me when I see this happen to a stock that I haven’t seen teased! Hindsight highlights the good, bad, and envious:-)

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

Leave a Reply

Be the First to Comment!